Status
Conditions
About
Several surrogate biomarkers including natriuretic peptide(NP), and growth differentiation factor-15(GDF-15) and ST2 has prognostic significance in heart failure(HF), and reductions in its value may predict clinical improvement. However, there are limited data regarding the prognostic value of these biomarkers during short-term follow-up after discharge in acute decompensated heart failure. The purpose of this study is to evaluate the prognostic value of short-term follow-up surrogate biomarkers for predicting prognosis of hospitalized patients with acute decompensated heart failure.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: the diagnosis of Heart failure requires the following
Exclusion Criteria:
Loading...
Central trial contact
Dong-Hyuk Cho, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal